(Q58239456)

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Structure and functions of influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Structural basis for the function and inhibition of an influenza virus proton channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Structure and mechanism of the M2 proton channel of influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Zanamivir: a review of its use in influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Zanamivir: an update of its use in influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Oseltamivir: a review of its use in influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

The evolution of influenza resistance and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Neuraminidase inhibitors for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Rational design of potent sialidase-based inhibitors of influenza virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-A resolution: implications for the catalytic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Noncovalent binding between guanidinium and anionic groups: focus on biological- and synthetic-based arginine/guanidinium interactions with phosph[on]ate and sulf[on]ate residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Practical Total Synthesis of the Anti-Influenza Drug GS-4104

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

New, azide-free transformation of epoxides into 1,2-diamino compounds: synthesis of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (Tamiflu).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Tamiflu: the supply problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

New, efficient synthesis of oseltamivir phosphate (Tamiflu) via enzymatic desymmetrization of a meso-1,3-cyclohexanedicarboxylic acid diester

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Symmetry-based design for the chemoenzymatic synthesis of oseltamivir (Tamiflu) from ethyl benzoate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

A concise and flexible synthesis of the potent anti-influenza agents tamiflu and tamiphosphor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

De Novo Synthesis of Tamiflu via a Catalytic Asymmetric Ring-Opening of meso -Aziridines with TMSN 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

A Concise Synthesis of (−)-Oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor oseltamivir from 1,3-butadiene and acrylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

A synthesis of Tamiflu by using a barium-catalyzed asymmetric Diels-Alder-type reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

The Synthetic Development of the Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate (Tamiflu ® ): A Challenge for Synthesis & Process Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

A practical synthesis of (-)-oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

A Synthesis of Oseltamivir (Tamiflu) Starting from d-Mannitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Two approaches toward the formal total synthesis of oseltamivir phosphate (Tamiflu): catalytic enantioselective three-component reaction strategy and L-glutamic acid strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Synthesis of oseltamivir and tamiphosphor from N-acetyl-d-glucosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

High-yielding synthesis of the anti-influenza neuramidase inhibitor (-)-oseltamivir by three "one-pot" operations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

High-yielding synthesis of the anti-influenza neuraminidase inhibitor (-)-oseltamivir by two "one-pot" sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Organocatalytic Michael addition of aldehydes to protected 2-amino-1-nitroethenes: the practical syntheses of oseltamivir (Tamiflu) and substituted 3-aminopyrrolidines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

A practical and azide-free synthetic approach to oseltamivir from diethyl D-tartrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

An iron carbonyl approach to the influenza neuraminidase inhibitor oseltamivir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Efficient formal synthesis of oseltamivir phosphate (Tamiflu) with inexpensive D-ribose as the starting material.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Sugar-based synthesis of Tamiflu and its inhibitory effects on cell secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

One-bead-one-inhibitor-one-substrate screening of neuraminidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

A practical synthesis of zanamivir phosphonate congeners with potent anti-influenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

The evolution of synthetic oral drug properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Amazing stability of the arginine-phosphate electrostatic interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Guanidinium group: a versatile moiety inducing transport and multicompartmentalization in complementary membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Antiviral therapy for influenza : a clinical and economic comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Antiviral agents active against influenza A viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Galactose-conjugates of the oseltamivir pharmacophore--new tools for the characterization of influenza virus neuraminidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

‘TamiGold’: phospha-oseltamivir-stabilised gold nanoparticles as the basis for influenza therapeutics and diagnostics targeting the neuraminidase (instead of the hemagglutinin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544

Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCCS.201300544